1. Home
  2. News
  3. NATCO Pharma Limited
  4. Press Release May 17 2021
More NATCO Pharma Limited news
NATCO Pharma LimitedNSE: NATCOPHARM

Press Release May 17 2021

May 17, 2021 at 3:04 PM EDT · Issued by NATCO Pharma Limited

Filed with NSE · May 17, 2021 at 3:04 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/press-release-may-17-2021-7

Watch NATCO Pharma's latest callNATCO Pharma (NSE:NATCOPHARM) Q2 2027 Earnings Call · Replay · Nov 13↗

NATCO Pharma Limited on 6ix

Earlier from NATCO Pharma

  • Press Release May 03 2021May 3, 2021
  • Press Release Apr 26 2021Apr 26, 2021
  • NATCO Pharma receives tentative approval for Ibrutinib tablets (generic for IMBRUVICA) ANDA in the US marketApr 13, 2021
  • Press Release Apr 10 2021Apr 10, 2021
  • NATCO Pharma forays into Pheromone based technology for Integrated Pest ManagementMar 16, 2021

Later from NATCO Pharma

  • Press Release May 21 2021May 21, 2021
  • Press Release May 22 2021May 22, 2021
  • Press Release Jun 14 2021Jun 14, 2021
  • Press Release Jul 07 2021Jul 7, 2021
  • Press Release Aug 03 2021Aug 3, 2021
All NATCO Pharma news releases↗

Follow NATCO Pharma into a list and get an email when it puts out news.

Follow NATCO Pharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer